{"name":"Albert Chiou","slug":"albert-chiou","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxObFR1REFYajd3a2FFMVExa3BJWEZrdElhSnBqQmw0VGRDaG1LbFlHRkJTT3NiZmdtcHp3WmduUGNOZGJZYS1ZalI5QmdKcTN5WEEyeUprYkhsMnlIVVNuakJWZ1hYempRbkV0X1BEbEc4SlVtOEVuWEJzemFKVWQ3UHNjVkhmb09NZDg0OHViVGhFNExOdWpTalVSZHUxUjg1YjdkdlV2RU85YU1Kamc?oc=5","date":"2025-05-19","type":"pipeline","source":"Dermatology Times","summary":"Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD - Dermatology Times","headline":"Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNY3Jrc1k2ZjV5eUpyX2JwN2Y1V3NiTnNXdmZuVkJvaWZCWE9OYzNRMGJCVTlWOEZvSDdjLUVJVS1pem5xd1NsLWctc0RTSHVxUnJIQU9DZXJUYVdsb0xqMTFyamFPNmlDVi1TTmJWeVFVeWE4dDBidFRHdUtic0U1Q0xDRW5GNEt4eTNCVE5abnc1YUZnWlJJd3FLeUVuR1o1V3p0MnRIeGtUeGtyU1RBR1BaS1BSbkU3RjBIYWwzQjZlbXQweDB5Zg?oc=5","date":"2025-05-08","type":"trial","source":"Dermatology Times","summary":"Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial - Dermatology Times","headline":"Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}